• I-BET151 (GSK1210151A): Practical Guide for BET Inhibition A

  2026-04-30

  I-BET151 (GSK1210151A) is a selective BET bromodomain inhibitor designed to modulate transcriptional programs in cancer biology. This compound is suitable for apoptosis and cell cycle arrest assays, particularly in models such as MLL-fusion leukemia and glioblastoma, but is not intended for diagnostic or clinical applications.

• Amiloride (MK-870): Mechanistic Insights for Next-Gen Ion Ch

  2026-04-29

  Explore how Amiloride (MK-870) advances sodium channel research by revealing precise mechanisms of epithelial ion transport and cellular signaling. This article delivers a deeper mechanistic and translational perspective distinct from traditional workflow guides.

• Cl-Amidine trifluoroacetate salt: Advancing PAD4 Assays in C

  2026-04-29

  Cl-Amidine (trifluoroacetate salt) enables precise inhibition of PAD4, unlocking new frontiers in cancer and immune modulation research. This guide delivers actionable protocols, troubleshooting insights, and translational links grounded in recent discoveries and validated workflows.

• A 83-01 ALK-5 Inhibitor: Transforming Organoid & EMT Researc

  2026-04-28

  A 83-01, a selective ALK-5 inhibitor from APExBIO, empowers researchers to precisely control TGF-β signaling, enabling advanced organoid modeling and epithelial-mesenchymal transition (EMT) studies. With nanomolar potency, high selectivity, and robust protocol adaptability, it streamlines workflows in cancer, fibrosis, and stem cell research.

• MEK1/2 and c-Myc:MAX Counteract PRC2 Repression of TERT in h

  2026-04-28

  This study reveals how MEK1/2-ERK signaling and c-Myc:MAX complexes prevent PRC2-mediated silencing of the TERT gene in human pluripotent stem cells. These findings clarify the interplay between kinase signaling, transcription factor binding, and epigenetic repression, offering mechanistic insights relevant to stem cell biology and epigenetic cancer research.

• Panobinostat (LBH589): Translational Advances in HDAC Inhibi

  2026-04-27

  Explore how Panobinostat (LBH589) powers translational breakthroughs in epigenetic regulation and oncology research. This in-depth guide uniquely examines its role in combinatorial therapies and mechanistic precision, setting it apart from standard cell assay discussions.

• Strategic Use of nor-Binaltorphimine in Pain Circuit Analysi

  2026-04-27

  This thought-leadership article provides translational researchers with mechanistic insights and strategic guidance on leveraging nor-Binaltorphimine dihydrochloride—a selective κ-opioid receptor antagonist—for dissecting pain modulation circuits. Integrating breakthrough findings on descending brain-to-spinal pathways, it frames best practices for experimental design, protocol optimization, and clinical translation, while positioning APExBIO’s product as an indispensable tool in opioid receptor pharmacology.

• Evaluating Low-Cost Microfluidic Mixers for LNP-mRNA Product

  2026-04-26

  This study rigorously assesses low-cost microfluidic mixers for manufacturing lipid nanoparticles (LNPs) encapsulating mRNA, revealing that these accessible methods maintain high encapsulation efficiency and particle uniformity. The findings support broader adoption of bench-scale and high-throughput LNP production, with direct implications for mRNA delivery research and assay reproducibility.

• Caspase-4 Colorimetric Assay Kit: Precision in Pyroptosis Re

  2026-04-25

  Unlock reproducible, quantitative detection of caspase-4 activity with the APExBIO Caspase-4 Colorimetric Assay Kit. This workflow-driven guide synthesizes experimental best practices, troubleshooting insights, and reference-backed innovation to elevate your inflammasome and pyroptosis studies.

• Super-Enhancers Drive SLC7A11-Mediated Disulfidptosis in Pro

  2026-04-24

  This study identifies a super-enhancer–FOXA1–SLC7A11 axis as a critical regulator of disulfidptosis in prostate cancer, linking metabolic vulnerability to tumor progression. These findings highlight a novel, targetable pathway that may inform future therapeutic strategies, especially in glucose-deprived tumor microenvironments.

• BRD4770: Epigenetic Precision in G9a Inhibition for Cancer R

  2026-04-24

  Explore how BRD4770, a G9a histone methyltransferase inhibitor, uniquely advances epigenetic cancer research with mechanistic insight and practical guidance. This article provides a deeper analysis of BRD4770’s application and protocol optimization, differentiating it from standard workflows.

• Epigenetic Regulator Targeting Shapes Immune Signatures in M

  2026-04-23

  Anichini et al. systematically profiled the immune-modulatory impact of various epigenetic inhibitors in melanoma, uncovering that DNMT inhibition by guadecitabine most robustly upregulates immune-related gene signatures. Their work delineates mechanistic differences among epigenetic drug classes and informs rational combinations with immunotherapy.

• Panobinostat (LBH589): Translational Innovation in HDAC Inhi

  2026-04-23

  Explore the unique translational power of Panobinostat (LBH589) as a broad-spectrum HDAC inhibitor in advanced cancer and virotherapy research. This article unveils new mechanistic insights and assay strategies for researchers seeking next-generation epigenetic tools.

• I-BET151 (GSK1210151A): Technical Guidance for BET Inhibitio

  2026-04-22

  I-BET151 (GSK1210151A) is a selective BET bromodomain inhibitor designed to disrupt BRD2, BRD3, and BRD4-driven transcriptional programs, supporting cancer biology and mechanistic studies such as apoptosis and cell cycle arrest assays. It should be used where precise, targeted BET inhibition is required, and is not suitable for diagnostic or medical applications.

• BGJ398 (NVP-BGJ398): Advancing Functional Assays in FGFR Res

  2026-04-22

  Explore how BGJ398 (NVP-BGJ398) elevates FGFR-driven malignancies research by enabling precision functional assays and developmental biology insights. Uncover protocol guidance, cross-species mechanistic findings, and unique experimental perspectives.

11449 records 1/764 page Next 12345 下5页 Last page